van Baal P - Search Results

1

Distributional consequences of including survivor costs in economic evaluations.

Kellerborg K, Brouwer W, Versteegh M, Wouterse B, van Baal P. Kellerborg K, et al. Among authors: van baal p. Health Econ. 2021 Sep;30(10):2606-2613. doi: 10.1002/hec.4401. Epub 2021 Jul 30. Health Econ. 2021. PMID: 34331343 Free PMC article.

2

Economics and public health: engaged to be happily married!

Brouwer W, Van Exel J, Van Baal P, Polder J. Brouwer W, et al. Among authors: van exel j, van baal p. Eur J Public Health. 2007 Apr;17(2):122-3. doi: 10.1093/eurpub/ckl074. Epub 2006 Sep 8. Eur J Public Health. 2007. PMID: 16963790 No abstract available.

3

van Baal PH, Feenstra TL, Hoogenveen RT, de Wit GA, Brouwer WB. van Baal PH, et al. Health Econ. 2007 Apr;16(4):421-33. doi: 10.1002/hec.1181. Health Econ. 2007. PMID: 17039573

4

Increasing tobacco taxes: a cheap tool to increase public health.

van Baal PH, Brouwer WB, Hoogenveen RT, Feenstra TL. van Baal PH, et al. Health Policy. 2007 Jul;82(2):142-52. doi: 10.1016/j.healthpol.2006.09.004. Epub 2006 Oct 16. Health Policy. 2007. PMID: 17050031

5

Lifetime medical costs of obesity: prevention no cure for increasing health expenditure.

van Baal PH, Polder JJ, de Wit GA, Hoogenveen RT, Feenstra TL, Boshuizen HC, Engelfriet PM, Brouwer WB. van Baal PH, et al. PLoS Med. 2008 Feb;5(2):e29. doi: 10.1371/journal.pmed.0050029. PLoS Med. 2008. PMID: 18254654 Free PMC article.

6

Rappange DR, van Baal PH, van Exel NJ, Feenstra TL, Rutten FF, Brouwer WB. Rappange DR, et al. Pharmacoeconomics. 2008;26(10):815-30. doi: 10.2165/00019053-200826100-00003. Pharmacoeconomics. 2008. PMID: 18793030 Review.

7

Future costs in economic evaluation. A comment on Lee.

Feenstra TL, van Baal PH, Gandjour A, Brouwer WB. Feenstra TL, et al. J Health Econ. 2008 Dec;27(6):1645-9; discussion 1650-1. doi: 10.1016/j.jhealeco.2008.07.007. Epub 2008 Jul 25. J Health Econ. 2008. PMID: 18823670

8

Lifestyle intervention: from cost savings to value for money.

Rappange DR, Brouwer WB, Rutten FF, van Baal PH. Rappange DR, et al. J Public Health (Oxf). 2010 Sep;32(3):440-7. doi: 10.1093/pubmed/fdp079. Epub 2009 Aug 7. J Public Health (Oxf). 2010. PMID: 19666690

9

Healthcare costs and obesity prevention: drug costs and other sector-specific consequences.

Rappange DR, Brouwer WB, Hoogenveen RT, Van Baal PH. Rappange DR, et al. Pharmacoeconomics. 2009;27(12):1031-44. doi: 10.2165/11319900-000000000-00000. Pharmacoeconomics. 2009. PMID: 19908927

10

Standardizing the inclusion of indirect medical costs in economic evaluations.

van Baal PH, Wong A, Slobbe LC, Polder JJ, Brouwer WB, de Wit GA. van Baal PH, et al. Pharmacoeconomics. 2011 Mar;29(3):175-87. doi: 10.2165/11586130-000000000-00000. Pharmacoeconomics. 2011. PMID: 21184618

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters